Schistosoma mansoni adult microsomal antigens, a serologic reagent. I. Systematic fractionation, quantitation, and characterization of antigenic components.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 6337216)

Published in J Immunol on March 01, 1983

Authors

V C Tsang, K R Tsang, K Hancock, M A Kelly, B C Wilson, S E Maddison

Articles citing this

Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective. Clin Med Res (2004) 1.14

Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol (2005) 1.03

Rapid, low-technology field- and laboratory-applicable enzyme-linked immunosorbent assays for immunodiagnosis of Schistosoma mansoni. J Clin Microbiol (1991) 1.01

National serologic survey of Haematobium schistosomiasis in Morocco: evidence for elimination. Am J Trop Med Hyg (2011) 0.95

Serodiagnosis of parasitic diseases. Clin Microbiol Rev (1991) 0.92

Microvolume, kinetic-dependent enzyme-linked immunosorbent assay for amoeba antibodies. J Clin Microbiol (1984) 0.89

Collaborative study on antigens for immunodiagnosis of Schistosoma japonicum infection. Bull World Health Organ (1987) 0.88

Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunology (1988) 0.83

Mechanism of anemia in Schistosoma mansoni-infected school children in Western Kenya. Am J Trop Med Hyg (2012) 0.82

Sera of Schistosoma japonicum-infected patients cross-react with diagnostic 31/32 kD proteins of S. mansoni. Clin Exp Immunol (1987) 0.81

Immunoaffinity fractionation of Schistosoma mansoni worm antigens using human antibodies and its application for serodiagnosis. Immunology (1986) 0.80

Improving the detection limit of quantitative diagnosis of anti-S. haematobium antibodies using Falcon Assay Screening Test (FAST) ELISA by developing a new standard curve. Parasitol Res (2010) 0.78

Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression. Parasitol Res (2013) 0.77

Selecting targets for the diagnosis of Schistosoma mansoni infection: An integrative approach using multi-omic and immunoinformatics data. PLoS One (2017) 0.75

Articles by these authors

Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15

Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol (1983) 6.86

India ink staining of proteins on nitrocellulose paper. Anal Biochem (1983) 5.78

Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl Opt (1989) 4.42

Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell (1993) 3.84

Optical properties of Intralipid: a phantom medium for light propagation studies. Lasers Surg Med (1992) 3.34

In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol (1998) 3.18

Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys (2005) 3.17

Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis (1996) 2.83

Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA (1998) 2.74

Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG) Lancet (1993) 2.66

Material properties and structure-function relationships in the menisci. Clin Orthop Relat Res (1990) 2.61

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci (1996) 2.57

Organization of minicircle genes for guide RNAs in Trypanosoma brucei. Cell (1990) 2.28

Fetal acidemia associated with regional anesthesia for elective cesarean delivery. Obstet Gynecol (1995) 2.23

Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory. IEEE Trans Biomed Eng (1989) 2.08

Spatially resolved absolute diffuse reflectance measurements for noninvasive determination of the optical scattering and absorption coefficients of biological tissue. Appl Opt (1996) 2.05

Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood (1996) 1.99

Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis (1991) 1.95

Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell (1997) 1.91

Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88

A Monte Carlo model for the absorption and flux distributions of light in tissue. Med Phys (1984) 1.87

Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol (2009) 1.84

Lack of effect of walking on labor and delivery. N Engl J Med (1998) 1.76

Double-staining procedure for the fluorescent treponemal antibody absorption (FTA-ABS) test. Br J Vener Dis (1979) 1.73

Quantitative, single-tube, kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA). Methods Enzymol (1983) 1.72

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain (1993) 1.64

Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis (1999) 1.63

Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA). J Immunol (1984) 1.63

Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet (1991) 1.63

A systematic approach to assessing the clinical significance of genetic variants. Clin Genet (2013) 1.63

Material properties of the normal medial bovine meniscus. J Orthop Res (1989) 1.62

Immunoglobulin specificity for the fluorescent treponemal antibody-absorption test conjugate. J Clin Microbiol (1976) 1.58

Maternal age and malformations in singleton births. Obstet Gynecol (2000) 1.56

Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg (1992) 1.53

Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg (2001) 1.52

Fatal neurologic complication of parenteral feeding through a central vein catheter. Am J Dis Child (1984) 1.50

Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc (2001) 1.48

The use of India ink as an optical absorber in tissue-simulating phantoms. Phys Med Biol (1992) 1.44

Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem (1999) 1.43

Schistosomiasis in Lake Malawi. Lancet (1996) 1.42

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41

Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci (1998) 1.39

Skin equivalents. Lancet (1989) 1.39

Comparative evaluation of commercial precipitating antisera against human IgM and IgM. J Lab Clin Med (1970) 1.38

Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol (1999) 1.38

Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. J Infect Dis (1997) 1.38

A specific diagnostic antigen of Echinococcus granulosus with an apparent molecular weight of 8 kDA. Am J Trop Med Hyg (1989) 1.38

Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia (2011) 1.37

Nasotracheal intubation in the neonate: physiologic responses and effects of atropine and pancuronium. J Pediatr (1984) 1.37

Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg (1996) 1.37

Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg (1999) 1.36

Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat Res (1997) 1.35

Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg (1998) 1.33

Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay. Clin Chem (1980) 1.33

Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J Immunol Methods (1986) 1.32

Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid. Br J Cancer (2005) 1.32

The total condylar prosthesis. 10- to 12-year results of a cemented knee replacement. J Bone Joint Surg Br (1989) 1.32

Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol (2007) 1.30

Amoebic gel-diffusion precipitin-test. Clinical evaluation in amoebic liver abscess. Lancet (1965) 1.29

Fractionation of Pneumocystis carinii antigens used in an enzyme-linked immunosorbent assay for antibodies and in the production of antiserum for detecting Pneumocystis carinii antigenemia. J Clin Microbiol (1982) 1.27

The efficacy of arthroscopy following total knee replacement. Arthroscopy (1997) 1.26

Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet Rec (1997) 1.25

Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett (2002) 1.23

An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet Med (2011) 1.23

Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology (1999) 1.22

Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens. Am J Trop Med Hyg (1986) 1.21

Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board). Am J Trop Med Hyg (1994) 1.20

Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry (1995) 1.20

The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci (1999) 1.18

Amoebic gel-diffusion precipitin-test. Clinical evaluation in acute amoebic dysentery. Lancet (1966) 1.18

Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg (2001) 1.17

Electroencephalographic activity after brain death. Arch Neurol (1987) 1.17

In vivo near-infrared Raman spectroscopy: demonstration of feasibility during clinical gastrointestinal endoscopy. Photochem Photobiol (2000) 1.16

Detection of specific antibody by enzyme-linked immunosorbent assay and antigenemia by counterimmunoelectrophoresis in humans infected with Pneumocystis carinii. J Clin Microbiol (1982) 1.16

Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology (2002) 1.16

Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru. Am J Epidemiol (1992) 1.15

Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther (2000) 1.14

A solubilization technique for photosensitizer quantification in ex vivo tissue samples. J Photochem Photobiol B (1997) 1.13

In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem Photobiol (1990) 1.12

Monte Carlo modeling of light propagation in highly scattering tissues--II: Comparison with measurements in phantoms. IEEE Trans Biomed Eng (1989) 1.12

In vivo quantification of fluorescent molecular markers in real-time by ratio imaging for diagnostic screening and image-guided surgery. Lasers Surg Med (2007) 1.11

Optical and thermal characterization of natural (Sepia officinalis) melanin. Photochem Photobiol (1994) 1.11

Effects of femtosecond laser irradiation on osseous tissues. Lasers Surg Med (2007) 1.11

Evaluation of serologic tests for Pneumocystis carinii antibody and antigenemia in patients with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis (1984) 1.11

Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy. J Photochem Photobiol B (1990) 1.09

Diagnosis of paragonimiasis by immunoblot. Am J Trop Med Hyg (1988) 1.09

Coagulation studies f plasmas from healthy domesticated animals and persons. Am J Vet Res (1981) 1.08

The physics of photodynamic therapy. Phys Med Biol (1986) 1.08

Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience (2000) 1.07

Calibration of prestained protein molecular weight standards for use in the "Western" or enzyme-linked immunoelectrotransfer blot techniques. Anal Biochem (1984) 1.07